Breast cancer following ovarian cancer: Public health and screening implications for the leading female malignancy through Meta-analysis
Clinical Epidemiology and Global Health · 2026-09 · 41 · 102427
DOI: 10.1016/j.cegh.2026.102427 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Epidemiology and Global Health, 2026-09. Verfasst von Nada Bennani Mechita und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the incidence of breast cancer after a diagnosis of ovarian cancer, considering key factors such as BRCA mutation status and age at ovarian cancer diagnosis.
Methods
A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Scopus, Web of Science, and Google Scholar were searched on September 24, 2025. Studies reporting the incidence of breast cancer among women with a prior ovarian cancer diagnosis were included. Two reviewers independently performed data extraction and quality assessment. The pooled incidence rate was estimated using a random-effects model, with heterogeneity assessed by the I 2 statistic. Subgroup analyses were conducted based on BRCA status, and meta-regression was performed according to age.
Results
Eleven studies were included after duplicate removal and screening. The pooled incidence of breast cancer following ovarian cancer was 4.02% (95% CI: 2.33–6.84), with high heterogeneity (I 2 = 98.5%). The incidence was significantly higher in studies including BRCA mutation carriers compared with those including unselected ovarian cancer patients (7.53% vs. 1.34%, p < 0.001).
Conclusion
Although the overall risk of breast cancer after ovarian cancer appears moderate, BRCA mutation carriers face a substantially increased risk. Surveillance strategies should be individualized, taking into account BRCA status and age at ovarian cancer diagnosis.
Zitieren
APA
Mechita, N. B., Hilali, S. E., Mountassir, A. A., Messaoud, S., Razine, R., & Obtel, M. (2026). Breast cancer following ovarian cancer: Public health and screening implications for the leading female malignancy through Meta-analysis. Clinical Epidemiology and Global Health, 41, 102427. https://doi.org/10.1016/j.cegh.2026.102427
Vancouver
Mechita NB, Hilali SE, Mountassir AA, Messaoud S, Razine R, Obtel M. Breast cancer following ovarian cancer: Public health and screening implications for the leading female malignancy through Meta-analysis. Clinical Epidemiology and Global Health. 2026;41:102427. doi:10.1016/j.cegh.2026.102427
BibTeX
@article{Mechita2026,
author = {Mechita, Nada Bennani and Hilali, Samia El and Mountassir, Anas Ahmed and Messaoud, Sara and Razine, Rachid and Obtel, Majdouline},
title = {Breast cancer following ovarian cancer: Public health and screening implications for the leading female malignancy through Meta-analysis},
journal = {Clinical Epidemiology and Global Health},
year = {2026},
volume = {41},
pages = {102427},
doi = {10.1016/j.cegh.2026.102427}
}
EUVIMED